Apalutamide will lower the extent or impact of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of apalutamide, a strong CYP3A4 inducer, with medicines which have been CYP3A4 substrates can lead to decrease publicity to those medicines. It’s not true that Wymzya Fe will cause https://christopherh372kvi9.tdlwiki.com/user